Parametric Portfolio Associates’s Vaxart VXRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$66K Sell
13,095
-148,812
-92% -$754K ﹤0.01% 3607
2021
Q4
$1.01M Buy
161,907
+89,249
+123% +$609K ﹤0.01% 2779
2021
Q3
$578K Buy
72,658
+11,220
+18% +$92.4K ﹤0.01% 3037
2021
Q2
$460K Sell
61,438
-4,243
-6% -$29.6K ﹤0.01% 3122
2021
Q1
$397K Buy
65,681
+16,727
+34% +$129K ﹤0.01% 3601
2020
Q4
$280K Buy
48,954
+36,285
+286% +$231K ﹤0.01% 3628
2020
Q3
$84K Buy
+12,669
New +$113K ﹤0.01% 3818

Other funds holding VXRT

Parametric Portfolio Associates's VXRT Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Vaxart (VXRT) stake by 92% in Q1 2022, selling an estimated $754K and leaving 13,095 shares worth $66K. The position accounts for ﹤0.01% of the portfolio, ranked #3607.

Parametric Portfolio Associates first reported a position in VXRT in Q3 2020 and has held it in 7 quarters since. The position peaked at $1.01M in Q4 2021. 148 funds tracked by Wall St. Rank hold VXRT as of Q1 2022.

  • Parametric Portfolio Associates held 13,095 shares of Vaxart worth $66K as of Q1 2022.
  • Parametric Portfolio Associates sold 148,812 Vaxart shares in Q1 2022, an estimated $754K.
  • Vaxart made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3607 holding.
  • Parametric Portfolio Associates first reported a position in Vaxart in Q3 2020 and has held it in 7 quarters since.
  • Parametric Portfolio Associates's Vaxart position peaked at $1.01M in Q4 2021.
  • 148 funds tracked by Wall St. Rank held Vaxart as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.